Global Economy Faces Difficult Winter Despite Covid-19 Vaccine Hopes
December 01 2020 - 7:02AM
Dow Jones News
By Paul Hannon
The prospect of coronavirus vaccines on the horizon has boosted
hopes of an end to the pandemic-wrought downturn -- but first the
global economy could face a long and difficult winter.
Government restrictions and consumers' fear of infection will
continue to weigh on the global economy well into next year, even
as vaccine developments offer hope of an end to the pandemic, the
Organization for Economic Cooperation and Development said
Tuesday.
When the world's economy does come back, China will emerge as
the big winner, according to the research body, accounting for as
much as one-third of next year's recovery, as Western countries
slowly shake off the effects of 2020's record-setting
contractions.
Releasing new forecasts since a number of pharmaceutical
companies said their vaccines were highly effective in recent
tests, the OECD said governments must continue to provide support
to their economies to ensure a speedy return to pre-pandemic levels
of activity.
"It's not like we get a vaccine and in a month everything
returns to normal," said Laurence Boone, the OECD's chief
economist.
The group cut its growth forecasts for most leading economies,
citing a recent surge in infections across the Northern Hemisphere
that had prompted new restrictions on households and businesses and
caution among consumers.
It now expects the global economy to grow by 4.2% in 2021,
having contracted by the same degree this year. In September, when
it last released quarterly forecasts, it expected the economy to
grow by 5% next ear.
The OECD cut its forecast for economic growth in 2021 in the
U.S. to 3.2% from 4%, and its forecasts for the eurozone to 3.6%
from 5.1%. It left its growth forecast for China at 8%.
Those forecasts are based on what Ms. Boone said was a
"cautious" view of the logistics of manufacturing and deploying
vaccines, as well as levels of takeup in populations that may be
skeptical about safety.
The OECD expect most economies to be operating under some form
of constraint until the final months of 2021.
"For most of next year, we will have to rely on
non-pharmaceutical interventions to keep on living," Ms. Boone
said.
The OECD said the pace of the recovery would continue to be very
uneven across countries. In the final quarter of 2021, China's
economic output is expected to be 9.7% higher than it was in the
final three months of 2019. By contrast, Argentina's economic
output is forecast to be 8% lower.
U.S. output is expected to recover to its pre-pandemic level by
that time, but the eurozone's output is projected to be 3% lower,
and the U.K.'s 6.4% down on the final quarter of last year.
According to those projections, China will account for roughly
one-third of the increase in global economic output next year. Ms.
Boone said the pandemic appeared to have accelerated China's rise
as an economic power.
"There is a rebalancing in the global economy," she said.
The OECD said the world outlook remained highly uncertain. A
more rapid deployment of effective vaccines could boost global
growth to 5% in 2021 and 5.5% in 2022, while a slower deployment
would weaken the expansion to 1.45% next year and 2.2% in 2022.
The Paris-based body provides policy advice to its members,
which include the U.S. It urged governments to continue helping the
neediest households and businesses and provide broader-based
stimulus to boost demand and speed the rebound.
Ms. Boone said the OECD's forecasts assumed fresh fiscal
stimulus in both the U.S. and Europe, adding that it would be a
blow to confidence not to provide it.
"It would be reassuring for businesses and households to know we
have learned from the last crisis," she said.
Write to Paul Hannon at paul.hannon@wsj.com
(END) Dow Jones Newswires
December 01, 2020 06:47 ET (11:47 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.